Depressed suicide attempters have smaller hippocampus than depressed patients without suicide attempts

Journal of Psychiatric Research

Volumn 61, Issue , 2015, Pages 13-18

  Colle, Romain ^a   Chupin, Marie ^b,c,d,e,f   Cury, Claire ^b,c,d,e,f   Vandendrie, Christophe ^g   Gressier, Florence ^a   Hardy, Patrick ^a   Falissard, Bruno ^a   Colliot, Olivier ^b,c,d,e,f   Ducreux, Denis ^g   Corruble, Emmanuelle ^a  

^a INSERM U1178   (France)

^b INSERM   (France)

^c CNRS   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e INSTITUT DU CERVEAU ET DE LA MOELLE ÉPINIÈRE   (France)

^f INRIA ROCQUENCOURT   (France)

^g BICÊTRE HOSPITAL   (France)

Author keywords

Automatic segmentation; Biomarker; Hippocampal volume; Major depressive disorder; MRI; Suicide attempt

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HAMILTON DEPRESSION RATING SCALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MIDDLE AGED; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK ASSESSMENT; SUICIDE ATTEMPT; ADOLESCENT; COMPLICATION; PATHOLOGY; PSYCHOLOGY; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RISK FACTORS; SUICIDE, ATTEMPTED; YOUNG ADULT;

EID: 84921471794     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2014.12.010     Document Type: Article

References (33)

1. Bergouignan L., Chupin M., Czechowska Y., Kinkingnéhun S., Lemogne C., Le Bastard G., et al. Can voxel based morphometry, manual segmentation and automated segmentation equally detect hippocampal volume differences in acute depression?. Neuroimage 2009, 45:29-37.
2. Bostwick J.M., Pankratz V.S. Affective disorders and suicide risk: a reexamination. Am J Psychiatry 2000, 157:1925-1932.
3. Caine D., Watson J.D. Neuropsychological and neuropathological sequelae of cerebral anoxia: a critical review. JInt Neuropsychol Soc 2000, 6:86-99.
4. Campbell S., Macqueen G. The role of the hippocampus in the pathophysiology of major depression. JPsychiatry Neurosci 2004, 29:417-426.
5. Chupin M., Hammers A., Bardinet E., Colliot O., Liu R.S., Duncan J.S., et al. Fully automatic segmentation of the hippocampus and the amygdala from MRI using hybrid prior knowledge. Med Image Comput Comput Assist Interv 2007, 10:875-882.
6. Chupin M., Hammers A., Liu R.S., Colliot O., Burdett J., Bardinet E., et al. Automatic segmentation of the hippocampus and the amygdala driven by hybrid constraints: method and validation. Neuroimage 2009, 46:749-761.
7. Colliot O., Chételat G., Chupin M., Desgranges B., Magnin B., Benali H., et al. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology 2008, 248:194-201.
8. David D.J., Samuels B.A., Rainer Q., Wang J.W., Marsteller D., Mendez I., et al. Neurogenesis-dependent and -independent effects of fluoxetine in an animal model of anxiety/depression. Neuron 2009, 62:479-493.
9. Gurden H., Takita M., Jay T.M. Essential role of D1 but not D2 receptors in the NMDA receptor-dependent long-term potentiation at hippocampal-prefrontal cortex synapses invivo. JNeurosci 2000, 20:RC106.
10. Hamilton M. Arating scale for depression. JNeurol Neurosurg Psychiatry 1960, 23:56-62.
11. Henley S.M., Ridgway G.R., Scahill R.I., Klöppel S., Tabrizi S.J., Fox N.C., et al. EHDN Imaging Working Group. Pitfalls in the use of voxel-based morphometry as a biomarker: examples from huntington disease. AJNR Am J Neuroradiol 2010, 31:711-719.
12. Hwang J.P., Lee T.W., Tsai S.J., Chen T.J., Yang C.H., Lirng J.F., et al. Cortical and subcortical abnormalities in late-onset depression with history of suicide attempts investigated with MRI and voxel-based morphometry. Geriatr Psychiatry Neurol 2010, 23:171-184.
13. Institute of Medicine (US) Committee on Pathophysiology and Prevention of Adolescent and Adult Suicide Reducing suicide: a national imperative 2002, The National Academies Press.
14. Jay T.M., Burette F., Laroche S. NMDA receptor-dependent longterm potentiation in the hippocampal afferent fibre system to the prefrontal cortex in the rat. Eur J Neurosci 1995, 7:247-250.
15. Jollant F., Lawrence N.L., Olié E., Guillaume S., Courtet P. The suicidal mind and brain: a review of neuropsychological and neuroimaging studies. World J Biol Psychiatry 2011, 12:319-339.
16. Keilp J.G., Sackeim H.A., Brodsky B.S., Oquendo M.A., Malone K.M., Mann J.J. Neuropsychological dysfunction in depressed suicide attempters. Am J Psychiatry 2001, 158:735-741.
17. Kempton M.J., Salvador Z., Munafò M.R., Geddes J.R., Simmons A., Frangou S., et al. Structural neuroimaging studies in major depressive disorder. Meta-analysis and comparison with bipolar disorder. Arch Gen Psychiatry 2011, 68:675-690.
18. Kronmüller K.T., Pantel J., Köhler S., Victor D., Giesel F., Magnotta V.A., et al. Hippocampal volume and 2-year outcome in depression. Br J Psychiatry 2008, 192:472-473.
19. Lee B.H., Kim Y.K. Potential peripheral biological predictors of suicidal behavior in major depressive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2011, 35:842-847.
20. MacQueen G., Frodl T. The hippocampus in major depression: evidence for the convergence of the bench and bedside in psychiatric research?. Mol Psychiatry 2011, 16:252-264.
21. Mann J.J., Currier D., Stanley B., Oquendo M.A., Amsel L.V., Ellis S.P. Can biological tests assist prediction of suicide in mood disorders?. Int J Neuropsychopharmacol 2006, 9:465-474.
22. McGowan P.O., Sasaki A., D'Alessio A.C., Dymov S., Labonté B., Szyf M., et al. Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse. Nat Neurosci 2009, 12:342-348.
23. Monkul E.S., Hatch J.P., Nicoletti M.A., Spence S., Brambilla P., Lacerda A.L., et al. Fronto-limbic brain structures in suicidal and non-suicidal female patients with major depressive disorder. Mol Psychiatry 2007, 12:360-366.
24. Nock M.K., Hwang I., Sampson N.A., Kessler R.C. Mental disorders, comorbidity and suicidal behavior: results from the National Comorbidity Survey Replication. Mol Psychiatry 2010, 15:868-876.
25. O'Carroll P.W., Berman A.L., Maris R.W., Moscicki E.K., Tanney B.L., Silverman M.M. Beyond the Tower of Babel: a nomenclature for suicidology. Suicide Life Threat Behav 1996, 26:237-252.
26. Richard-Devantoy S., Berlim M.T., Jollant F. Ameta-analysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders. Psychol Med 2014, 44:1663-1673.
27. Richard-Devantoy S., Berlim M.T., Jollant F. Suicidal behaviour and memory: a systematic review and meta-analysis. World J Biol Psychiatry 2014, 12:1-23.
28. Ridgway G.R., Henley S.M., Rohrer J.D., Scahill R.I., Warren J.D., Fox N.C. Ten simple rules for reporting voxel-based morphometry studies. Neuroimage 2008, 40:1429-1435.
29. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. JClin Psychiatry 1998, 59:22-33.
30. Sheline Y.I., Sanghavi M., Mintun M.A., Gado M.H. Depression duration but not age predicts hippocampal volume loss in medically healthy women with recurrent major depression. JNeurosci 1999, 19:5034-5043.
31. Soloff P.H., Pruitt P., Sharma M., Radwan J., White R., Diwadkar V.A. Structural brain abnormalities and suicidal behavior in borderline personality disorder. JPsychiatr Res 2012, 46:516-525.
32. Spoletini I., Piras F., Fagioli S., Rubino I.A., Martinotti G., Siracusano A., et al. Suicidal attempts and increased right amygdala volume in schizophrenia. Schizophr Res 2011, 125:30-40.
33. Van Petten C. Relationship between hippocampal volume and memory ability in healthy individuals across the lifespan: review and meta-analysis. Neuropsychologia 2004, 42:1394-1413.